Pfizer Limited
Pfizer Limited, a subsidiary of the global pharmaceutical giant Pfizer Inc., is headquartered in India and operates extensively across the Asia-Pacific region. Founded in 1849, Pfizer has established itself as a leader in the pharmaceutical industry, focusing on innovative medicines and vaccines that address critical health challenges. The company is renowned for its diverse portfolio, which includes treatments in areas such as oncology, cardiology, immunology, and infectious diseases. Pfizer Limited's commitment to research and development has led to significant breakthroughs, making its products unique in efficacy and safety. With a strong market position, Pfizer Limited has achieved numerous accolades for its contributions to healthcare, including the rapid development of vaccines during public health emergencies. This dedication to improving patient outcomes solidifies its reputation as a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Pfizer Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pfizer Limited's score of 29 is lower than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pfizer Limited's reported carbon emissions
In 2023, Pfizer Limited reported carbon emissions of approximately 3,658,000 kg CO2e in India, comprising 63,000 kg CO2e from Scope 1 and 3,653,000 kg CO2e from Scope 2 emissions. This reflects a commitment to transparency in their environmental impact, as they have disclosed emissions data for both scopes. Pfizer has set ambitious reduction targets, aiming for a 26% decrease in carbon footprint per million tablets produced, reducing from 0.98 tonnes CO2e to 0.72 tonnes CO2e by 2024. This target applies to both Scope 1 and Scope 2 emissions, demonstrating their focus on improving operational efficiency and sustainability. The company has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. Overall, Pfizer Limited's climate commitments reflect a proactive approach to reducing their carbon footprint and enhancing their environmental performance in the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 149,000 | 00,000 |
| Scope 2 | 3,433,000 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pfizer Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
